Fact CheckerSign in

NCT05384145Recruiting

Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

A Type 2 Hybrid Effectiveness-implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Coastal Alabama

Source: ClinicalTrials.gov · Last updated 18 May 2026

Brief summary (registry, in English)

The purpose of this study is to adapt and evaluate a combination intervention that includes: (1) a data-driven approach to directed community-based HIV testing to areas with high need, (2) Project Connect to expedite linkage to care at time of diagnosis, (3) and a Rapid ART (antiretroviral therapy)Start program, all in Mobile County Health Department (MCHD) jurisdictions in Alabama.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
17 May 2022
Start date
27 Mar 2024
Primary completion date
31 Jan 2027
Lead sponsor
University of Alabama at Birmingham
Diseases
HIV
NCT number
NCT05384145

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 27 Mar 2024 to the primary completion date, 31 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Exclusion criteria include unwillingness or inability to provide informed consent.

Who the study is looking for

  • AIM 1 \& 3:
  • Fit into one of the following categories:
    • 1\) MCHD leadership, 2) ADPH leadership, 3) clinic administrators, 4) outreach testing specialists, 5) linkage coordinators and community health workers, 6) physicians, 7) nurses, 8) counselors all working at HIV care facilities in the six MCHD jurisdiction counties.
  • Over the age of 18 years old.
    • AIM 2: (IDIs)
  • Over the age of 13 years old
  • Tested for HIV in MCHD jurisdiction from time of COASTAL implementation to 36 months post-implementation start date.

Age in the registry: 13 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alabama at Birmingham
Coordinator of this site? Confirm its status
BirminghamUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.